ATE183231T1 - Durchflussvorrichtung und verfahren zur elektroporation - Google Patents

Durchflussvorrichtung und verfahren zur elektroporation

Info

Publication number
ATE183231T1
ATE183231T1 AT95939876T AT95939876T ATE183231T1 AT E183231 T1 ATE183231 T1 AT E183231T1 AT 95939876 T AT95939876 T AT 95939876T AT 95939876 T AT95939876 T AT 95939876T AT E183231 T1 ATE183231 T1 AT E183231T1
Authority
AT
Austria
Prior art keywords
flow
blood
patient
cells
chamber
Prior art date
Application number
AT95939876T
Other languages
English (en)
Inventor
Gunter A Hofmann
Henry R Kent
Original Assignee
Genetronics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetronics Inc filed Critical Genetronics Inc
Application granted granted Critical
Publication of ATE183231T1 publication Critical patent/ATE183231T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/18—Erythrocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/02—Electrical or electromagnetic means, e.g. for electroporation or for cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Electromagnetism (AREA)
  • Plant Pathology (AREA)
  • Sustainable Development (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Apparatuses And Processes For Manufacturing Resistors (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • External Artificial Organs (AREA)
AT95939876T 1994-10-12 1995-10-12 Durchflussvorrichtung und verfahren zur elektroporation ATE183231T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/320,966 US5545130A (en) 1992-04-08 1994-10-12 Flow through electroporation method

Publications (1)

Publication Number Publication Date
ATE183231T1 true ATE183231T1 (de) 1999-08-15

Family

ID=23248604

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95939876T ATE183231T1 (de) 1994-10-12 1995-10-12 Durchflussvorrichtung und verfahren zur elektroporation

Country Status (8)

Country Link
US (2) US5545130A (de)
EP (1) EP0785987B1 (de)
JP (1) JP3740664B2 (de)
AT (1) ATE183231T1 (de)
AU (1) AU691705B2 (de)
CA (1) CA2196610C (de)
DE (1) DE69511422T2 (de)
WO (1) WO1996012006A2 (de)

Families Citing this family (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5545130A (en) * 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
US6103084A (en) * 1995-06-06 2000-08-15 Eppendorf Netheler-Hinz Gmbh Apparatus for electroporation
US6041252A (en) * 1995-06-07 2000-03-21 Ichor Medical Systems Inc. Drug delivery system and method
US5879317A (en) * 1996-04-30 1999-03-09 Medtronic, Inc. Electrostatic blood defoamer for heart-lung machines
US5869326A (en) * 1996-09-09 1999-02-09 Genetronics, Inc. Electroporation employing user-configured pulsing scheme
US6090617A (en) * 1996-12-05 2000-07-18 Entremed, Inc. Flow electroporation chamber with electrodes having a crystalline metal nitride coating
US5903211A (en) * 1997-02-07 1999-05-11 Althin Medical, Inc. Medical treatment device with a user interface adapted for home or limited care environments
US5873849A (en) * 1997-04-24 1999-02-23 Ichor Medical Systems, Inc. Electrodes and electrode arrays for generating electroporation inducing electrical fields
US6055453A (en) * 1997-08-01 2000-04-25 Genetronics, Inc. Apparatus for addressing needle array electrodes for electroporation therapy
AU2868099A (en) * 1998-02-13 1999-08-30 Selective Genetics, Inc. Concurrent flow mixing methods and apparatuses for the preparation of gene therapy vectors and compositions prepared thereby
EP1075548A1 (de) 1998-05-04 2001-02-14 Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.V. Elektrische, integrierte nucleinsäureisolierung, -reinigung und -detektion
US6027488A (en) 1998-06-03 2000-02-22 Genetronics, Inc. Flow-through electroporation system for ex vivo gene therapy
US20040229363A1 (en) * 1998-06-24 2004-11-18 Ed Nolan High efficiency transfection based on low electric field strength, long pulse length
US6150148A (en) * 1998-10-21 2000-11-21 Genetronics, Inc. Electroporation apparatus for control of temperature during the process
AU3804100A (en) 1999-02-15 2000-09-04 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Method and sample support system for separating and processing substances in situ
US6326177B1 (en) 1999-08-04 2001-12-04 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Method and apparatus for intracellular electro-manipulation
US6448089B1 (en) 1999-10-12 2002-09-10 Aurora Biosciences Corporation Multiwell scanner and scanning method
US6586257B1 (en) 1999-10-12 2003-07-01 Vertex Pharmaceuticals Incorporated Multiwell scanner and scanning method
US6814933B2 (en) * 2000-09-19 2004-11-09 Aurora Biosciences Corporation Multiwell scanner and scanning method
CA2395492A1 (en) * 1999-12-22 2001-07-05 Diana Wang Method and apparatus for targeting localised electroporation
CA2401239A1 (en) * 2000-03-03 2001-09-13 Valentis, Inc. Improved poloxamer and poloxamine compositions for nucleic acid delivery
JP2004532654A (ja) 2000-05-22 2004-10-28 マーク・アンド・カンパニー・インコーポレイテッド 薬剤投与システム性能評価システム及び方法
US6686193B2 (en) 2000-07-10 2004-02-03 Vertex Pharmaceuticals, Inc. High throughput method and system for screening candidate compounds for activity against target ion channels
US7615356B2 (en) * 2000-07-10 2009-11-10 Vertex Pharmaceuticals (San Diego) Llc Ion channel assay methods
US20040009940A1 (en) * 2000-10-20 2004-01-15 Coleman Michael E. Gene delivery formulations and methods for treatment of ischemic conditions
US7029916B2 (en) * 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
US20040204669A1 (en) * 2001-07-05 2004-10-14 Hofmann Gunter A. Apparatus for electroporation mediated delivery for drugs and genes
WO2003018751A2 (en) 2001-08-22 2003-03-06 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
WO2003026599A1 (en) * 2001-09-26 2003-04-03 The Procter & Gamble Company Personal cleansing compositions comprising silicone resin-containing adhesives
CN100417419C (zh) 2001-10-26 2008-09-10 贝勒医学院 改变个体的瘦体重和骨特性的组合物和方法
WO2003047684A2 (en) * 2001-12-04 2003-06-12 University Of Southern California Method for intracellular modifications within living cells using pulsed electric fields
DE10208188B4 (de) * 2002-02-20 2006-05-24 Amaxa Gmbh Behälter mit zumindest einer Elektrode
US8209006B2 (en) * 2002-03-07 2012-06-26 Vgx Pharmaceuticals, Inc. Constant current electroporation device and methods of use
EP1480692A2 (de) 2002-03-07 2004-12-01 Merck & Co., Inc. Klinische spritze mit elektrischen stimulationsaspekten
US7245963B2 (en) * 2002-03-07 2007-07-17 Advisys, Inc. Electrode assembly for constant-current electroporation and use
AU2003225793A1 (en) * 2002-03-15 2003-09-29 Baxter Healthcare S.A. Methods and compositions for directing cells to target organs
US20050233993A1 (en) * 2002-06-05 2005-10-20 Kadonaga James T Methods for promoting homologous recombination
EP1565555A4 (de) * 2002-09-30 2008-07-09 Maxcyte Inc Vorrichtung und verfahren zur strämungselektroporation
EA009405B1 (ru) * 2002-12-03 2007-12-28 Дженетроникс, Инк. Планшеты и системы для крупномасштабной электропорации и способы их применения
US6969604B1 (en) 2003-06-20 2005-11-29 Yakovenko Sergey A Electroporation chamber
EP1660530A2 (de) 2003-08-04 2006-05-31 Advisys, Inc. Für canine spezifisches wachstumshormon freisetzendes hormon
US7521224B2 (en) * 2003-09-30 2009-04-21 The United States Of America As Represented By The Secretary Of The Navy Microelectronic cell electroporation array
CA2592891C (en) 2003-12-31 2013-05-28 Advisys, Inc. Reducing arthritis and lameness in subjects by growth hormone releasing hormone (ghrh) supplementation
DE602005027661D1 (de) 2004-01-20 2011-06-09 VGX Pharmaceuticals LLC Isetzendem hormon (ghrh) aus muskelzellen durch speziesspezifisches signalpeptid
WO2006080934A2 (en) * 2004-04-19 2006-08-03 Invitrogen Corporation Electroporation apparatus and methods
WO2005113820A2 (en) * 2004-05-12 2005-12-01 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber
WO2006063301A1 (en) * 2004-12-10 2006-06-15 Maxcyte, Inc. Genetically modified tumor cells as cancer vaccines
DE102005029414B4 (de) * 2005-06-24 2009-09-03 Forschungszentrum Karlsruhe Gmbh Verfahren zur Bestimmung des durch Elektroporation bewirkenden Aufschlussgrades biologischer Zellen
JP5826450B2 (ja) * 2005-07-22 2015-12-02 ザ ファウンドリー， エルエルシー 治療薬の送達のためのシステムおよび方法
US8058253B2 (en) 2006-07-06 2011-11-15 Vgx Pharmaceuticals, Inc. Growth hormone releasing hormone treatment to decrease cholesterol levels
WO2008048632A1 (en) 2006-10-17 2008-04-24 Vgx Pharmaceuticals, Inc. Electroporation devices and methods of using same for electroporation of cells in mammals
US20120078163A1 (en) 2009-05-27 2012-03-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Method of generating connective tissue
EP2603517B1 (de) * 2010-05-12 2023-07-19 Cellectis Dynamische misch- und elektroporationskammer und system dafür
EP2621522A2 (de) 2010-09-27 2013-08-07 China Agricultural University Kombinierter antigen- und dna-impfstoff zur vorbeugung und behandlung von autoimmunkrankheiten
CN103239734B (zh) 2012-02-10 2016-02-24 北京艾棣维欣生物技术有限公司 用于预防和/或治疗呼吸道合胞病毒感染的疫苗
SI2931304T1 (sl) 2012-12-13 2021-11-30 The Trustees Of The University Of Pennsylvania Cepivo proti WT1
WO2014194244A1 (en) 2013-05-30 2014-12-04 Duke University Enzyme-catalyzed synthesis of site-specific and stoichiometric biomolecule-polymer conjugates
US10364451B2 (en) 2013-05-30 2019-07-30 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US10392611B2 (en) 2013-05-30 2019-08-27 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
WO2015054012A1 (en) 2013-10-07 2015-04-16 The Trustees Of The University Of Pennsylvania Vaccines with interleukin-33 as an adjuvant
WO2015070027A1 (en) 2013-11-07 2015-05-14 University Of Southern California Use of ikk epsilon inhibitors to activate nfat and t cell response
CA2930695C (en) 2013-11-14 2024-05-14 Inovio Pharmaceuticals, Inc. Hiv-1 env dna vaccine plus protein boost
JP6412131B2 (ja) 2013-11-29 2018-10-24 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア ＭＥＲＳ‐ＣｏＶワクチン
CA3156357A1 (en) 2014-01-06 2015-07-09 The Trustees Of The University Of Pennsylvania Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy
KR102586707B1 (ko) 2014-10-01 2023-10-11 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 항원 및 어쥬번트로서 인터류킨-21을 갖는 백신
JP6734283B2 (ja) 2015-01-21 2020-08-05 フレッド ハッチンソン キャンサー リサーチ センター 遺伝子治療用ポイントオブケア及び／又はポータブルプラットフォーム
KR20170106453A (ko) 2015-01-29 2017-09-20 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 관문 억제제 및 백신 조합 및 면역요법을 위한 이들의 사용
WO2016154530A1 (en) 2015-03-26 2016-09-29 Duke University Targeted therapeutic agents comprising multivalent protein-biopolymer fusions
AU2016301391B2 (en) 2015-08-04 2022-07-28 Duke University Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same
US20190015520A1 (en) 2015-12-21 2019-01-17 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
WO2017173398A1 (en) 2016-04-01 2017-10-05 Duke University Alpha-helical peptide nanofibers as a self-adjuvanting vaccine platform
KR102443064B1 (ko) 2016-04-29 2022-09-14 이노비오 파마수티컬즈, 인크. 제제의 전달을 향상시키기 위한 콘드로이티나제 및/또는 히알루로니다제의 생체내 용도
WO2017210476A1 (en) 2016-06-01 2017-12-07 Duke University Nonfouling biosensors
US10233419B2 (en) 2016-06-30 2019-03-19 Zymergen Inc. Apparatuses and methods for electroporation
CN109890833A (zh) 2016-09-14 2019-06-14 杜克大学 用于递送亲水性药物的基于三嵌段多肽的纳米粒子
JP2020500150A (ja) 2016-09-23 2020-01-09 デューク ユニバーシティ 下限臨界溶液温度挙動を有する非反復かつ非構造的ポリペプチド
US10376495B2 (en) 2016-11-23 2019-08-13 University Of South Florida Small molecules that mimic or antagonize actions of granulocyte colony-stimulating-factor (G-CSF)
US11648200B2 (en) 2017-01-12 2023-05-16 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
US10813935B2 (en) 2017-02-23 2020-10-27 Transgenex Nanobiotech, Inc. Methods and compositions for treating drug resistance in cancer
US10272052B2 (en) 2017-02-24 2019-04-30 University Of South Florida Compositions and methods for the treatment of tauopathies
WO2018156989A1 (en) 2017-02-24 2018-08-30 University Of South Florida The hsp90 activator aha1 drives production of pathological tau aggregates
US11554097B2 (en) 2017-05-15 2023-01-17 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
US11680083B2 (en) 2017-06-30 2023-06-20 Duke University Order and disorder as a design principle for stimuli-responsive biopolymer networks
GB201710973D0 (en) 2017-07-07 2017-08-23 Avacta Life Sciences Ltd Scaffold proteins
WO2020028806A1 (en) 2018-08-02 2020-02-06 Duke University Dual agonist fusion proteins
KR102232757B1 (ko) * 2018-11-22 2021-03-26 (주)엑솔런스바이오테크놀로지 체외충격파를 이용한 표적물질 전달 장치
CN114340777A (zh) * 2019-07-02 2022-04-12 凯拓盘公司 用于机电递送的装置、系统和套件及其使用方法
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides
TW202128775A (zh) 2019-10-16 2021-08-01 英商阿法克塔生命科學有限公司 PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
KR20220088469A (ko) * 2019-10-25 2022-06-27 라이프 테크놀로지스 코포레이션 세포-함유 유체의 전기천공을 위한 시스템, 방법 및 장치
CN115867349A (zh) 2020-02-25 2023-03-28 艾诺奥医药品有限公司 针对冠状病毒的疫苗和使用方法
CN115803051A (zh) 2020-05-14 2023-03-14 艾诺奥医药品有限公司 用于复发性呼吸道乳头状瘤病的疫苗及其使用方法
GB202101299D0 (en) 2020-06-09 2021-03-17 Avacta Life Sciences Ltd Diagnostic polypetides and methods
CA3181680A1 (en) 2020-06-12 2021-12-16 University Of Rochester Encoding and expression of ace-trnas
USD965170S1 (en) 2020-10-23 2022-09-27 Life Technologies Corporation Electroporation device
WO2022234003A1 (en) 2021-05-07 2022-11-10 Avacta Life Sciences Limited Cd33 binding polypeptides with stefin a protein
TW202334196A (zh) 2021-10-07 2023-09-01 英商阿法克塔生命科學有限公司 Pd-l1結合多肽
WO2023057946A1 (en) 2021-10-07 2023-04-13 Avacta Life Sciences Limited Serum half-life extended pd-l1 binding polypeptides
WO2023150753A1 (en) 2022-02-07 2023-08-10 University Of Rochester Optimized sequences for enhanced trna expression or/and nonsense mutation suppression
WO2024102187A1 (en) 2022-11-07 2024-05-16 Pinetree Therapeutics, Inc. Combination therapy comprising bispecific antibodies comprising an nrp1 binding domain

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464166A (en) * 1981-06-12 1984-08-07 Frederic A. Bourke, Jr. Method for externally treating the blood
US4612007A (en) * 1981-06-16 1986-09-16 Edelson Richard Leslie Method and system for externally treating the blood
US4496443A (en) * 1982-06-08 1985-01-29 Mack Michael H Method for electrically introducing substances into liquid solution
DE3317415A1 (de) * 1983-05-13 1984-11-15 Kernforschungsanlage Jülich GmbH, 5170 Jülich Kammer zur behandlung von zellen im elektrischen feld
US4561961A (en) * 1984-07-27 1985-12-31 Biotronics Cooled microscope slide and electrode apparatus for use in live cell fusion system
US4849089A (en) * 1986-05-09 1989-07-18 Electropore, Inc. Disposable electromanipulation chamber
US5098843A (en) * 1987-06-04 1992-03-24 Calvin Noel M Apparatus for the high efficiency transformation of living cells
US5128257A (en) * 1987-08-31 1992-07-07 Baer Bradford W Electroporation apparatus and process
US4970154A (en) * 1987-10-09 1990-11-13 Baylor College Of Medicine Method for inserting foreign genes into cells using pulsed radiofrequency
US4832814A (en) * 1987-12-28 1989-05-23 E. I. Du Pont De Nemours And Company Electrofusion cell and method of making the same
US5545130A (en) * 1992-04-08 1996-08-13 Genetronics, Inc. Flow through electroporation method
US5501662A (en) * 1992-05-22 1996-03-26 Genetronics, Inc. Implantable electroporation method and apparatus for drug and gene delivery
US5464386A (en) * 1992-08-17 1995-11-07 Genetronics, Inc. Transdermal drug delivery by electroincorporation of vesicles
EP0690671B1 (de) * 1993-03-23 2004-08-04 Cbr Laboratories, Inc. Verfahren und vorrichtung zur einkapselung biologisch aktiver substanzen in zellen

Also Published As

Publication number Publication date
JPH10507364A (ja) 1998-07-21
CA2196610C (en) 2004-07-20
US5545130A (en) 1996-08-13
DE69511422D1 (de) 1999-09-16
EP0785987B1 (de) 1999-08-11
DE69511422T2 (de) 2000-02-03
AU4153696A (en) 1996-05-06
WO1996012006A3 (en) 1996-08-01
WO1996012006A2 (en) 1996-04-25
CA2196610A1 (en) 1996-04-25
US5676646A (en) 1997-10-14
JP3740664B2 (ja) 2006-02-01
AU691705B2 (en) 1998-05-21
EP0785987A2 (de) 1997-07-30

Similar Documents

Publication Publication Date Title
ATE183231T1 (de) Durchflussvorrichtung und verfahren zur elektroporation
ES2117871T3 (es) Terapia electroporetica mediante genes y medicamentos, por campos electricos inducidos.
US6027488A (en) Flow-through electroporation system for ex vivo gene therapy
DE69530283D1 (de) Elektroporation und iontophorese vorrichtung für die abgabe von medikamenten und genen in zellen
US5135478A (en) Multi-signal electrical transdermal drug applicator
US20020147424A1 (en) Transdermal magnetic drug delivery system and method
JPS5573271A (en) Nonnpermeation type chemical sample injection method and its device
US6361665B1 (en) Device for electroactivating fluids and preparations consisting of electroactivated fluids
DE69929303D1 (de) Wegwerfset zum umlaufwaschen von blutzellen
CA2266347A1 (en) Electroporation and iontophoresis catheter with porous balloon
DE59914211D1 (de) Vorrichtung zur bestimmung des verteilungsvolumens eines blutinhaltsstoffes während einer blutbehandlung
DE69323488T2 (de) Vorrichtung zur trennung einer mischung
ATE129570T1 (de) Vorrichtung zum feststellen der viskositätsänderung eines flüssigen elektrolyts mittels depolarisierungswirkung.
DE69018966T2 (de) Verfahren zum kontinuierlichen überwachen der arbeitsweise eines ausgabesystems und vorrichtung zur durchführung des verfahrens.
EP0820776A3 (de) Apparat zur extrakorporalen Blutbehandlung
ATE38721T1 (de) Verfahren zum ueberwachen einer gaskonzentration in einer fluessigkeit.
DE60034757D1 (de) Verbesserte Vorrichtung zur ohmischen Heizung eines flüssigen Körpers, Behandlungsanlage die selbige benutzt, und Behandlungsverfahren eines flüssigen Körpers mittels ohmischer Heizung
ATE210497T1 (de) Methode und vorrichtung zur zuführung von elektromagnetischer energie in einer lösung
ATE360471T1 (de) Vorrichtung und verfahren zur trennung von molekülen und bewegung von fluiden mittels elektrophorese
EP0569634A1 (de) Elektrisches System mit mehreren Signalen zur transdermalen Medikamentenverabreichung
RU2008119500A (ru) Устройство мониторинга образования тромба и способ мониторинга образования тромба
ATE362716T1 (de) Verfahren und vorrichtung zur behandlung von flüssigkeiten
JPS5451980A (en) Device of regulating quantity of ultrafiltration
RU94043399A (ru) Способ электро-физико-химической обработки жидкости и/или жидкостно-газовой среды
SU1839984A1 (ru) Устройство для исследования и тренировки обонятельного анализатора животного

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties